FDA Investigator: Jie He

- Jie He first started conducting FDA inspections in 2012, with the last inspection in 2024. Over that time, Jie He has conducted 16 inspections at 13 companies across 15 sites.

Get Jie He's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Lonza Netherlands B.V., Geleen | 2024

Out-of-stock
Jie He
Biologics Form 483

FDA 483 Resilience US, Inc., Durham | 2024

Out-of-stock
Jie He
Biologics Form 483

FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC, Sanford | 2023

Out-of-stock
Jie He
Biologics Form 483

FDA 483 Berkshire Sterile Manufacturing, Inc., Lee | 2023

Out-of-stock
Jie He
Biologics Form 483

FDA 483 Therapure Biopharma Inc, Mississauga | 2020

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Sanofi Pasteur, Neuville Sur Saone | 2018

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Sanofi Pasteur, Val De Reuil | 2018

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Adimmune Corporation, Taichung City | 2016

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Baxter Healthcare GmbH - Baxter Vaccine AG, Orth An Der Donau | 2015

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Baxter Aktiengesellschaft, Vienna | 2015

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Octapharma AB, Stockholm | 2014

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Baxalta US Inc., Milford | 2014

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Biogen Idec, Inc., Research Triangle Park | 2013

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Biogen Idec, Inc., Research Triangle Park | 2013

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Octapharma Pharmazeutika Produktionsges, m.b.h., Vienna | 2012

Out-of-stock
Jie He
Biologic Form 483

FDA 483 Octapharma AB, Stockholm | 2012

Out-of-stock
Jie He
Biologic Form 483